Signal2026-08-11
ClinicalTrials.gov

[PHASE1] Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults

Part of

Next Generation Viral Therapeutics

Open primary sourceRead on Substack